Lunai Bioworks Inc.
Lunai Bioworks Inc. (RENB) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · RENB · as of Jun 9, 2026
Key Statistics
Explore Lunai Bioworks Inc. Data
renb stock data · financialsFinancial Snapshot
Full FinancialsCompetitors & Peers
renb competitorsRENB
ALLK
ANGN
FRLN
GRCE
IRDStock Performance
Full HistoryAbout Lunai Bioworks Inc.
Lunai Bioworks Inc. Lunai Bioworks, Inc. functions as a pre-clinical stage biotechnology enterprise, concentrating its efforts on pioneering genetically modified cell and immunotherapeutic platforms. These advanced techn…
what is lunai bioworks inc. · renb stock overview · lunai bioworks inc. company profile · who is lunai bioworks inc. ceo · renb NASDAQ · lunai bioworks inc. headquarters · lunai bioworks inc. business segments
About Stock Overview & Key Data
Lunai Bioworks Inc. (RENB) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Feb 7, 2018. As of the latest trading session, RENB stock price is $1.42, with a market capitalization of $32.9M. The stock has returned -73.70% over the past 12 months and -81.39% year-to-date.
In fiscal year 2025, Lunai Bioworks Inc. reported revenue of —. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Lunai Bioworks Inc. (RENB) stock price is $1.42. The stock is traded on NASDAQ under the ticker symbol RENB. The 52-week range is $1.12 – $21.00.